These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 6847261)

  • 21. [Diagnosis and prognosis of polymyalgia rheumatica and giant cell arteritis].
    ter Maaten JC; van de Kaa CA; Hoorntje SJ; Hillen HF
    Ned Tijdschr Geneeskd; 1991 Jan; 135(2):64-8. PubMed ID: 1990310
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Giant cell arteritis and polymyalgia rheumatica: diagnostic criteria].
    Marie I
    Rev Med Interne; 2013 Jul; 34(7):403-11. PubMed ID: 23498714
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polymyalgia rheumatica in biopsy proven giant cell arteritis does not constitute a different subset but differs from isolated polymyalgia rheumatica.
    González-Gay MA; García-Porrúa C; Vázquez-Caruncho M
    J Rheumatol; 1998 Sep; 25(9):1750-5. PubMed ID: 9733456
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating CD8+ T cells in polymyalgia rheumatica and giant cell arteritis: a review.
    Martinez-Taboada VM; Blanco R; Fito C; Pacheco MJ; Delgado-Rodriguez M; Rodriguez-Valverde V
    Semin Arthritis Rheum; 2001 Feb; 30(4):257-71. PubMed ID: 11182026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The spectrum of conditions mimicking polymyalgia rheumatica in Northwestern Spain.
    Gonzalez-Gay MA; Garcia-Porrua C; Salvarani C; Olivieri I; Hunder GG
    J Rheumatol; 2000 Sep; 27(9):2179-84. PubMed ID: 10990231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of giant cell arteritis and polymyalgia rheumatica.
    Meskimen S; Cook TD; Blake RL
    Am Fam Physician; 2000 Apr; 61(7):2061-8, 2073. PubMed ID: 10779249
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Challenges in the diagnosis of polymyalgia rheumatica and related giant cell arteritis.
    González-Gay MA; Vicente-Rabaneda EF; Martínez-López JA; Largo R; Heras-Recuero E; Castañeda S
    Expert Rev Clin Immunol; 2023 May; 19(5):517-526. PubMed ID: 36896659
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polymyalgia rheumatica and giant cell arteritis--An ophthalmic emergency.
    Durkin SR; Athanasiov PA; Crompton JL
    Aust Fam Physician; 2006 Nov; 35(11):889-91. PubMed ID: 17099810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary Care Vasculitis: Polymyalgia Rheumatica and Giant Cell Arteritis.
    Pioro MH
    Prim Care; 2018 Jun; 45(2):305-323. PubMed ID: 29759126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic difficulties in polymyalgia rheumatica cases with normal erythrocyte sedimentation rate and C-reactive protein values.
    Kara M; Alp G; Koç AM
    Medicine (Baltimore); 2023 Sep; 102(39):e35385. PubMed ID: 37773830
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Laboratory investigations including liver in polymyalgia rheumatica/giant cell arteritis.
    Kyle V
    Baillieres Clin Rheumatol; 1991 Dec; 5(3):475-84. PubMed ID: 1807822
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polymyalgia rheumatica and giant cell arteritis.
    Cimmino MA; Salvarani C
    Baillieres Clin Rheumatol; 1995 Aug; 9(3):515-27. PubMed ID: 7497536
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Giant cell arteritis and polymyalgia rheumatica: an update.
    González-Gay MA; Pina T
    Curr Rheumatol Rep; 2015 Feb; 17(2):6. PubMed ID: 25618572
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polymyalgia rheumatica without significantly increased erythrocyte sedimentation rate. A more benign syndrome.
    González-Gay MA; Rodríguez-Valverde V; Blanco R; Fernández-Sueiro JL; Armona J; Figueroa M; Martínez-Taboada VM
    Arch Intern Med; 1997 Feb; 157(3):317-20. PubMed ID: 9040299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biomarkers in the era of targeted therapy in giant cell arteritis and polymyalgia rheumatica: is it possible to replace acute-phase reactants?
    Carvajal Alegria G; Nicolas M; van Sleen Y
    Front Immunol; 2023; 14():1202160. PubMed ID: 37398679
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Temporal arteritis and polymyalgia rheumatica: two aspects of one disease.
    Miller RD; Ferguson EC
    Postgrad Med; 1979 Nov; 66(5):177-80, 182. PubMed ID: 493186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Soluble interleukin 2 receptors in polymyalgia rheumatica/giant cell arteritis. Clinical and laboratory correlations.
    Salvarani C; Macchioni P; Boiardi L; Rossi F; Casadei Maldini M; Mancini R; Beltrandi E; Spacca C; Lodi L; Portioli I
    J Rheumatol; 1992 Jul; 19(7):1100-6. PubMed ID: 1512765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic errors in polymyalgia rheumatica and temporal arteritis.
    Bretza J; Prete P; Martin D
    South Med J; 1981 Oct; 74(10):1270-3. PubMed ID: 7292073
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glucocorticoids for Management of Polymyalgia Rheumatica and Giant Cell Arteritis.
    Matteson EL; Buttgereit F; Dejaco C; Dasgupta B
    Rheum Dis Clin North Am; 2016 Feb; 42(1):75-90, viii. PubMed ID: 26611552
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alpha 1-antichymotrypsin, C-reactive protein and erythrocyte sedimentation rate in polymyalgia rheumatica and giant cell arteritis.
    Pountain GD; Calvin J; Hazleman BL
    Br J Rheumatol; 1994 Jun; 33(6):550-4. PubMed ID: 8205403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.